Improved recombinant vectors based on cucumber mosaic virus

The CMV recombinant vector with specific nucleotides and tags enhances foreign protein expression in plants, addressing inefficiencies in current vectors and providing superior expression efficiency.

JP2024542353AActive Publication Date: 2024-11-15KT&G CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024518263
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-03-23
Filing Date
2023-11-10
Publication Date
2024-11-15
Estimated Expiration
2043-11-10

AI Technical Summary

Technical Problem

Current gene transfer vectors for plants are not efficient in expressing foreign proteins, necessitating the development of a more effective recombinant vector.

Method used

A cucumber mosaic virus (CMV) recombinant vector is developed, incorporating specific nucleotides (SEQ ID NO:1) with a multiple cloning site (MCS) and tags (2xFLAG and 6xHIS) for enhanced protein expression, and transformed into a microorganism like Agrobacterium for inoculation into plants.

Benefits of technology

The CMV recombinant vector significantly enhances foreign protein expression in plants, offering improved efficiency compared to existing vectors, suitable for various plant species and research applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024542353000001_ABST
    Figure 2024542353000001_ABST
Patent Text Reader

Abstract

One aspect relates to an improved recombinant vector based on the cucumber mosaic virus. The recombinant vector according to one embodiment can significantly increase the efficiency of foreign protein expression in plants, and has a significantly higher efficiency of foreign protein expression than existing recombinant vectors, and can therefore be widely used in the production and research of useful proteins in various plant species.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] This application claims priority to Korean Patent Application No. 10-2022-0150990, filed on November 11, 2022, and Korean Patent Application No. 10-2023-0038110, filed on March 23, 2023, the entire specification of which is incorporated herein by reference.

[0002] The present invention relates to a cucumber mosaic virus (CMV)-based recombinant vector. [Background technology]

[0003] When a plant virus infects a host plant, it causes a systemic infection within a few days and uses the host's elements to replicate its own genome. During this replication process, the virus expresses large amounts of its own proteins within the plant cells. In addition, the virus genome is small, and the genome structure and gene expression mechanism can be regulated through molecular biological manipulation.

[0004] Research is being actively conducted to utilize these characteristics of plant viruses to develop them into gene transfer vectors by manipulating the genetic structure of the viruses so that foreign genes can be inserted and expressed, but there is a continuing demand for the development of more efficient vectors.

[0005] Against this background, the inventors conducted research efforts to develop a vector suitable for significantly increasing the expression level of a target protein, and as a result, they confirmed that a recombinant vector based on cucumber mosaic virus can significantly enhance the expression of a target protein, thereby completing the invention. Summary of the Invention [Problem to be solved by the invention]

[0006] One aspect provides a cucumber mosaic virus (CMV) recombinant vector comprising a nucleotide sequence according to SEQ ID NO:1.

[0007] Another aspect provides a transformed microorganism transformed with the recombinant vector.

[0008] Yet another aspect provides a method for producing a protein comprising the steps of creating a cucumber mosaic virus recombinant vector comprising a nucleotide sequence according to SEQ ID NO:1, transforming the recombinant vector into a fungus, and inoculating the transformed fungus into a plant.

[0009] However, the problems to be solved by the present invention are not limited to those mentioned above, and other problems not mentioned will be clearly understood by a person having ordinary skill in the art from the following description. [Means for solving the problem]

[0010] One embodiment provides a cucumber mosaic virus (CMV) recombinant vector comprising a nucleotide sequence according to SEQ ID NO:1.

[0011] The cucumber mosaic virus recombinant vector may further comprise a nucleotide sequence according to SEQ ID NO: 2, and may further comprise a nucleotide sequence according to SEQ ID NO: 3. The cucumber mosaic virus recombinant vector may further comprise a nucleotide sequence according to SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3, but is not limited thereto.

[0012] The Cucumber Mosaic Virus (CMV) is the virus that occurs most frequently and causes serious damage in domestic pepper cultivation, and is a positive-sense single stranded RNA virus that has a wide host range, infecting 885 plants in 65 genera and consisting of three segmented genomes. Cucumber Mosaic Virus (CMV) isolates can be classified into subgroups IA, IB, and II based on their base sequences, and among Cucumber Mosaic Virus (CMV) isolates, P0 type CMV-Fny (CMV-Fny strain) belongs to subgroup IA, and P1 type CMV-GTN (CMV-GTN strain) belongs to subgroup IB. In the present specification, the CMV-GTN refers to a highly pathogenic P1 type that was isolated purely from the chili pepper variety 'Cheongyang' grown in a chili pepper farm in Goesan County, Chungbuk-do in 2013 (Res. Plant Dis. 21(2): 99-102 (2015)).

[0013] According to one embodiment, the nucleotide sequence of SEQ ID NO: 1 also includes a multiple cloning site (MCS) operably linked to allow for the insertion of a foreign gene, and further includes a 2xFLAG tag and a 6xHIS tag following the MCS for detection and extraction of the expressed foreign protein, such that the protein produced by the recombinant vector also includes the 2xFLAG tag and the 6xHIS tag at the C-terminus.

[0014] As used herein, the term "recombinant vector" refers to a vector capable of expressing a foreign gene of interest in a host cell, and includes essential regulatory elements operably linked to allow the gene insert to be expressed. Suitable vectors include a signal sequence or leader sequence for membrane targeting or secretion in addition to expression regulatory sequences such as a promoter, operator, initiation codon, termination codon, polyadenylation signal, and enhancer, and can be prepared in a variety of ways depending on the purpose.

[0015] As used herein, the term "operably linked" means that a gene whose expression is required and its regulatory sequences are joined to each other in a manner that allows gene expression.

[0016] Another aspect provides a transformed microorganism transformed with the recombinant vector.

[0017] In the transformed microorganism, the portion that overlaps with the recombinant vector will not be described.

[0018] According to one embodiment, the microorganism is also of the genus Agrobacterium.

[0019] Yet another aspect provides a method for producing a protein comprising the steps of creating a cucumber mosaic virus recombinant vector comprising a nucleotide sequence according to SEQ ID NO:1, transforming the recombinant vector into a fungus, and inoculating the transformed fungus into a plant.

[0020] The protein produced by the protein production method also contains a 2xFLAG tag and a 6xHIS tag at the C-terminus.

[0021] In the protein production method, the description of the parts overlapping with those of the recombinant vector and transformed microorganism will be omitted. Effect of the Invention

[0022] According to one embodiment, the efficiency of foreign protein expression in plants can be significantly improved by using the cucumber mosaic virus-based recombinant vector. The recombinant vector according to this embodiment has a significantly higher efficiency of foreign protein expression than existing recombinant vectors, and can be widely used in the production of useful proteins and related research in various plant species. [Brief description of the drawings]

[0023] [Figure 1A] FIG. 1 shows the structures of pCMV-GTN-R1, pCMV-GTN-R2, and pCMV-GTN-R3 according to one embodiment of the improved cucumber mosaic virus-based vector structure. [Figure 1B] FIG. 2 shows the structure of pCMV-R3V according to one embodiment of the improved cucumber mosaic virus-based vector structure. [Figure 1C] FIG. 2 shows the structure of pCMV-R2V-B2 according to one embodiment of the improved cucumber mosaic virus-based vector structure. [Figure 1D] FIG. 1 shows the structure of pCMV-R3V-GFP combined with fluorescence to confirm the effect of pCMV-R3V according to one embodiment of the present invention in the structure of an improved cucumber mosaic virus-based vector. [Figure 1E] FIG. 2 shows the structures of pCMV-Fny-R1 and pCMV-Fny-R2 according to one embodiment of the improved cucumber mosaic virus-based vector structure. [Figure 1F] FIG. 1 shows the structure of PZP-GFP according to one embodiment of the improved cucumber mosaic virus-based vector structure. [Figure 2A] This is a diagram showing a comparative experiment with PZP-GFP to evaluate the expression efficiency of the CMV-GTN-GFP combination vector (pCMV-GTN-R1+pCMV-GTN-R2+pCMV-R3V-GFP). [Figure 2B] This figure shows a comparative experiment with the pCMV-Fny-R1 + pCMV-Fny-R2 + pCMV-R3V-GFP combination vector to evaluate the expression efficiency of the CMV-GTN-GFP combination vector (pCMV-GTN-R1 + pCMV-GTN-R2 + pCMV-R3V-GFP). [Figure 3A] This is a diagram showing the GFP expression level confirmed using a fluorescence measurement device to evaluate the expression efficiency of the CMV-GTN-B2-GFP combination vector (pCMV-R1+pCMV-R2V-B2+pCMV-R3V-GFP). [Figure 3B]This figure shows the results of SDS PAGE analysis of proteins extracted from the inoculation site 2 days after inoculation in order to evaluate the expression efficiency of the CMV-GTN-B2-GFP combination vector (pCMV-R1 + pCMV-R2V-B2 + pCMV-R3V-GFP). [Figure 3C] This is a diagram showing GFP band quantitative analysis performed using ImageJ to evaluate the expression efficiency of the CMV-GTN-B2-GFP combination vector (pCMV-R1 + pCMV-R2V-B2 + pCMV-R3V-GFP). [Figure 3D] FIG. 1 shows the GFP expression level per fresh weight to evaluate the expression efficiency of the CMV-GTN-B2-GFP combination vector (pCMV-R1+pCMV-R2V-B2+pCMV-R3V-GFP). DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0024] The present invention will be described in more detail below with reference to examples. However, these examples are merely for illustrative purposes and the scope of the present invention is not limited to these examples.

[0025] As used herein, the singular forms include the plural forms unless the context clearly indicates otherwise. Also, as used herein, "comprise," "include," and / or "comprising," "including" specify the presence of stated features, numbers, steps, operations, members, elements, and / or groups thereof, but do not exclude the presence or addition of one or more other features, numbers, operations, members, elements, and / or groups.

[0026] Working Example 1. Construction of improved cucumber mosaic virus-based vectors Hereinafter, a method for producing an improved vector according to an embodiment will be described with reference to Figures 1A to 1F. Figures 1A to 1F are schematic diagrams illustrating a method for producing an improved vector based on cucumber mosaic virus (CMV) according to an embodiment. Specifically, they show schematic diagrams of a cucumber mosaic virus (CMV) infectious cDNA clone, a recombinant vector, and a recombinant clone constructed for overexpression of green fluorescent protein (GFP).

[0027] The pCass-Rz vector was used as a binary vector for constructing a gene overexpression vector based on Cucumber Mosaic Virus (CMV). The pCass-Rz vector contains the left border of T-DNA, the double 35S promoter of CaMV, multiple cloning sites (MCS) (StuI, KpnI, XbaI, BamHI), a cis-cleaving ribozyme sequence (Rz), a 35S terminator (T), and the right border of T-DNA, in that order, and can be transformed into Agrobacterium and transfer the target gene to plants via agroinfiltration. In addition, the pCass-Rz vector contains a kanamycin resistance gene, and when transformed into E. coli and Agrobacterium, transformants can be selectively cultured.

[0028] To generate Cucumber Mosaic Virus (CMV)-based recombinant protein overexpression vectors, we used an infectious cDNA clone (see Virus Evolution, Volume 6, Issue 2, July 2020, veaa070) of the previously isolated CMV-GTN (Cucumber Mosaic Virus isolated from chili pepper) strain. The genome of Cucumber Mosaic Virus (CMV) is composed of three RNA segments, RNA1, RNA2, and RNA3. RNA1 codes for the 1a gene involved in RNA replication, while RNA2 codes for the 2a gene, a replicase, and the 2b gene, a gene silencing suppressor. RNA3 codes for the movement protein (MP) and coat protein (CP) genes of the virus.

[0029] Genomic DNAs of RNA1, RNA2, and RNA3 of highly pathogenic CMV-GTN strains isolated from chili peppers in Korean fields were amplified by RT-PCR. PCR products of each genomic RNA were cloned using the restriction enzyme sites in the MCS of pCass-RZ vector. The resulting infectious cDNA clones of CMV-GTN RNA1, RNA2, and RNA3 were named pCMV-GTN-R1 (SEQ ID NO: 3), pCMV-GTN-R2 (SEQ ID NO: 4), and pCMV-GTN-R3 (SEQ ID NO: 5), respectively. In addition, pCMV-R3V means the sequence of SEQ ID NO: 6, pCMV-R3V-GFP means the sequence of SEQ ID NO: 7, pCMV-Fny-R1 means the sequence of SEQ ID NO: 8, pCMV-Fny-R2 means the sequence of SEQ ID NO: 9, and PZP-GFP means the sequence of SEQ ID NO: 10.

[0030] Using an infectious clone of the CMV-GTN strain, we manipulated the genomic sequence of the CP ORF (open reading frame) of RNA3, which is expected to have high expression efficiency for foreign genes, and developed it into a cucumber mosaic virus (CMV)-based vector for overexpressing foreign proteins.

[0031] Specifically, the CP gene was removed from the RNA3 CP ORF, SpeI and MluI sites were introduced as MCS to enable insertion of a foreign gene, and a 2xFLAG tag and a 6xHIS tag were introduced after the MCS for detection and extraction of the expressed foreign protein. Therefore, when cloning is performed using the MCS, the expressed protein contains a 2xFLAG tag and a 6xHIS tag at the C-terminus. The CMV-GTN RNA3-based vector clone thus constructed was named pCMV-R3V (SEQ ID NO: 1).

[0032] While CMV RNA2 codes for the 2b gene, which is a gene silencing suppressor, in one embodiment, a recombinant CMV RNA2 infectious clone was constructed in which the 2b gene was replaced with the B2 gene of FHV (flock house virus), which is known to be an even more potent gene silencing suppressor, and was named pCMV-R2V-B2 (sequence number 2).

[0033] Specifically, the C-terminus of the 2b ORF of CMV RNA2 was removed, and the self-cleaving peptide (LLNFDLLKLAGDVESNPG / P) of FMDV (foot and mouth disease virus), an MluI site, and an FHV B2 sequence were introduced into the C-terminus of the 2b ORF. The B2 gene is expressed through the translation of the 2b ORF, and contains an additional proline (P) amino acid at the N-terminus while being cleaved by the FMDV self-cleaving peptide.

[0034] 2. Evaluation of expression efficiency of improved vectors (1) Cloning for expression efficiency evaluation In order to evaluate the efficiency of foreign gene expression in plants using the CMV-GTN-based vector prepared in 1. above, a clone was prepared by inserting the green fluorescent protein (GFP) gene into the SpeI and MluI restriction enzyme sites of pCMV-R3V. To this end, the green fluorescent protein (GFP) gene was amplified by PCR using primers (5'-GGACTAGTATGGTGAGCAAGGGCGAGGAG-3' and 5'-AACGACGCGTGAGGATCCCCTTGTACAGCTC-3'), and then treated with the SpeI and MluI restriction enzymes and inserted into the SpeI and MluI restriction enzyme sites of the pCMV-R3V vector. The clone into which the green fluorescent protein (GFP) was inserted was named pCMV-R3V-GFP (see Figures 1A to 1F). In addition, to generate infectious clones related to the highly pathogenic Cucumber Mosaic Virus (CMV) strain, instead of the CMV-Fny strain, pCass-Rz vector was used to generate pCMV-Fny-R1 and pCMV-Fny-R2 for CMV-Fny RNA1 and CMV-Fny RNA2, respectively, using the same cloning method as pCMV-GTN-R1 and pCMV-GTN-R2. For use as a control, PZP-GFP was prepared by inserting green fluorescent protein (GFP) into the PZP vector. The PZP vector contains, in order, the left border of T-DNA, the double 35S promoter of CaMV, TE (translation enhance element), MCS (StuI, SpeI), 35S terminator (T), and the right border of T-DNA, and can be transformed into Agrobacterium and transfer the target gene to a plant via agroinfiltration. The PZP vector also contains a spectinomycin resistance gene, and when transformed into Escherichia coli and Agrobacterium, transformants can be selectively cultured. The green fluorescent protein (GFP) gene was inserted into the StuI and SpeI restriction enzyme sites of the PZP vector to prepare a PZP-GFP clone.

[0035] Plasmid DNAs of pCMV-GTN-R1, pCMV-GTN-R2, pCMV-R3V-GFP, pCMV-R2V-B2, pCMV-Fny-R1, pCMV-Fny-R2 and PZP-GFP clones having the structures shown in Figures 1A to 1F were transformed into Agrobacterium strain EHA105. The transformed Agrobacterium was cultured in 5 ml of YEP liquid medium (containing 100 μg / ml kanamycin and 50 μg / ml rifampicin) with shaking at 30° C. for 16 hours, and then 1 ml of the primary culture was inoculated into 50 ml of fresh YEP medium (containing 100 μg / ml kanamycin, 50 μg / ml rifampicin, and 20 μM acetosyringone) and cultured with shaking at 30° C. for 6 hours. The culture was centrifuged at 4,800 G for 10 minutes to precipitate the Agrobacterium, which was then further suspended in MMA infiltration buffer (MS salts, 10 mM MES (pH 5.6), 200 μM acetosyringone) to a concentration of OD 0.7 at a wavelength of 600 nm. Thereafter, the suspension was cultured with shaking at 30° C. for 4 hours.

[0036] Agrobacterium suspensions transformed with each clone, either mixed in the same ratio as presented below or alone, were pressure infiltrated onto the hypocotyl surface of tobacco plant (N. benthamiana) leaves using a 1 ml syringe.

[0037] 1) CMV-GTN-GFP: Agrobacterium suspensions (OD 0.7) transformed with pCMV-GTN-R1, pCMV-GTN-R2, and pCMV-R3V-GFP were mixed in the same ratio and infiltrated.

[0038] 2) PZP-GFP: Agrobacterium suspension (OD 0.7) transformed with PZP-GFP was infiltrated alone.

[0039] 3) CMV-Fny-GFP: Agrobacterium suspensions (OD 0.7) transformed with pCMV-Fny-R1, pCMV-Fny-R2, and pCMV-R3V-GFP were mixed in the same ratio and infiltrated.

[0040] 4) CMV-GTN-B2-GFP: Agrobacterium suspensions (OD 0.7) transformed with pCMV-GTN-R1, pCMV-R2V-B2, and pCMV-R3V-GFP were mixed in the same ratio and infiltrated.

[0041] (2) Evaluation of GFP expression efficiency 1) Expression efficiency of the CMV-GTN-GFP combination vector After inoculating each combination of Agrobacterium suspension, the time-dependent expression of green fluorescent protein (GFP) at the inoculation site was observed using a fluorescence measurement device (FOBI system).

[0042] FIG. 2A is a comparative analysis of green fluorescent protein (GFP) expression efficiency between the CMV-GTN-GFP combination (pCMV-GTN-R1+pCMV-GTN-R2+pCMV-R3VGFP) and PZP-GFP.

[0043] Compared with PZP-GFP, which was constructed using a binary vector containing a 35S promoter that is widely used in plant transformation, the CMV-GTN-GFP combination (pCMV-GTN-R1+pCMV-GTN-R2+pCMV-R3V-GFP) was confirmed to express a very large amount of green fluorescent protein (GFP) (see Figure 2A). The amount of green fluorescent protein (GFP) expressed by the CMV-GTN-GFP combination was confirmed to be the highest on the second day after inoculation (2 dpi) and gradually decreased over time (see Figure 2A).

[0044] Based on the above results, it was confirmed that the vector containing pCMV-R3V represented by SEQ ID NO:1 can significantly enhance the expression of a foreign protein in plants.

[0045] Furthermore, in order to confirm whether the highly pathogenic CMV-GTN strain newly created in the Examples has a higher foreign protein expression efficiency as a vector than other cucumber mosaic virus (CMV) strains, the CMV-GTN-GFP combination was compared with the CMV-Fny-GFP combination (pCMV-Fny-R1+pCMV-Fny-R2+pCMV-R3V-GFP).

[0046] Figure 2B shows a comparison of the green fluorescent protein (GFP) expression efficiency between the CMV-GTN-GFP combination and the CMV-Fny-GFP combination (pCMV-Fny-R1+pCMV-Fny-R2+pCMVR3V-GFP). After inoculating each combination of Agrobacterium suspension, the time-dependent expression of green fluorescent protein (GFP) at the inoculation site was observed using a fluorescence measurement device (FOBI system).

[0047] As a result, it was confirmed that the CMV-GTN-GFP combination had a much higher green fluorescent protein (GFP) expression efficiency than the CMV-Fny-GFP combination (see FIG. 2B). Such results indicate that there may be differences in the efficiency of foreign gene overexpression as a vector depending on the Cucumber Mosaic Virus (CMV) strain, and that the CMV-GTN strain used in the examples has excellent effects as a foreign gene overexpression vector.

[0048] 2) Expression efficiency of the CMV-GTN-B2-GFP combination vector Next, to confirm whether the expression efficiency would be increased when using pCMV-R2V-B2, in which the CMV2b gene was replaced with the FHV B2 gene to express a more potent gene silencing suppressor, we compared the CMV-GTN-GFP combination with the CMV-GTN-B2-GFP combination (pCMV-GTN-R1 + pCMV-R2V-B2 + pCMV-R3V-GFP).

[0049] Figure 3A shows the time course of green fluorescent protein (GFP) expression at the inoculation site after inoculation with each combination of Agrobacterium suspension, observed using a fluorescence measurement device (FOBI system). Figure 3B shows SDS PAGE analysis of total protein extracted from the inoculation site two days after inoculation. Figure 3C shows the quantitative comparative analysis of the green fluorescent protein (GFP) band in B using ImageJ. Figure 3D shows the quantitative analysis of the green fluorescent protein (GFP) expression level of the recombinant CMVGTN-based vector relative to the plant fresh weight.

[0050] The expression efficiency in the inoculated tobacco plants was confirmed by a fluorescence measurement device (FOBI), and it was confirmed that the CMV-GTN-B2-GFP combination had a slightly higher expression efficiency than the CMV-GTN-GFP combination (see Figure 3A). To compare the green fluorescent protein (GFP) expression efficiency between the two combinations more accurately, total protein was extracted from the inoculation site two days after inoculation and SDS-PAGE analysis was performed. As a result, it was confirmed that the amount of green fluorescent protein (GFP) protein expressed using the CMV-GTN-based vector accounted for a very high percentage of the total extracted protein, and it was confirmed that the CMV-GTN-B2-GFP combination induced slightly more green fluorescent protein (GFP) expression than the CMV-GTN-GFP combination (Figure 3B). In addition, the image quantitative analysis program ImageJ was used to analyze it, and it was confirmed that the CMV-GTN-B2-GFP combination had a green fluorescent protein (GFP) expression efficiency that was increased by about 30% (see Figure 3C).

[0051] To analyze the amount of green fluorescent protein (GFP) expressed by the CMV-GTN-based vector relative to the plant fresh weight, cytoplasmic proteins were extracted from the inoculation site two days after inoculation and GFP quantitative analysis was performed using a GFP Quantification Kit (product number ab235672 (Abcam, UK)). The CMV-GTN-GFP combination showed a green fluorescent protein (GFP) expression efficiency of 2,846 ng per mg fresh weight, while the CMV-GTN-B2-GFP combination showed a green fluorescent protein (GFP) expression efficiency of 3,444 ng per mg fresh weight, which was approximately 20% higher (see Figure 3D).

[0052] Therefore, the green fluorescent protein (GFP) gene was cloned into each vector, and expressed in tobacco (Nicotiana benthamiana) plants, and the expression levels were compared and analyzed. As a result, it was found that the highly pathogenic CMV-GTN-based vector showed a much higher level of green fluorescent protein (GFP) expression than the CMV-Fny strain, which is commonly used in research. In addition, it was confirmed that the expression level of green fluorescent protein (GFP) increased by about 12% when pCMV-R2V-B2 was used compared to the wild-type CMV RNA2 infectious clone (pCMV-GTN-R2).

[0053] From the above results, it can be seen that the CMV-GTN-B2-GFP combination vector (pCMV-GTN-R1+pCMV-R2V-B2+pCMV-R3V-GFP) according to this embodiment shows a significantly improved expression efficiency in the expression of foreign proteins in plants.

[0054] The above description of the embodiments is merely illustrative, and a person having ordinary skill in the art will understand that various modifications and equivalent embodiments are possible. Therefore, the true scope of protection of the invention is defined by the appended claims, and all differences within the scope equivalent to the contents described in the claims should be interpreted as being included in the scope of protection defined by the claims.

Claims

1. A Cucumber Mosaic Virus (CMV) recombinant vector comprising a nucleotide sequence according to SEQ ID NO:

1.

2. 2. The cucumber mosaic virus recombinant vector of claim 1, further comprising a nucleotide sequence according to SEQ ID NO:

2.

3. 2. The cucumber mosaic virus recombinant vector of claim 1, further comprising a nucleotide sequence according to SEQ ID NO:

3.

4. The cucumber mosaic virus recombinant vector according to claim 1 , wherein the cucumber mosaic virus is a P1 type cucumber mosaic virus.

5. The cucumber mosaic virus recombinant vector according to claim 4, wherein the P1 type cucumber mosaic virus is a CMV-GTN strain.

6. A transformed microorganism transformed with a cucumber mosaic virus recombinant vector according to any one of claims 1 to 5.

7. Producing a cucumber mosaic virus recombinant vector comprising a nucleotide sequence according to SEQ ID NO:1; transforming the cucumber mosaic virus recombinant vector into a fungus; and a step of inoculating a plant with the transformed fungus.

8. The method for producing a protein according to claim 7 , wherein the protein produced by the method for producing a protein contains 2xFLAG tags and 6xHIS tags at the C-terminus.